Abilify and Diabetic gastroparesis - a phase IV clinical study of FDA data

Summary:

Diabetic gastroparesis is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years also take Seroquel, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Diabetic gastroparesis when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

What is Diabetic gastroparesis?

Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes) is found to be associated with 150 drugs and 244 conditions by eHealthMe. Check the latest studies of Diabetic gastroparesis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 15 people (0.02%) have Diabetic gastroparesis.

Could Abilify cause Diabetic gastroparesis?

Among these 15 people:

How long have people been on Abilify when they have Diabetic gastroparesis? *

What is the gender of people who have Diabetic gastroparesis when taking Abilify? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Diabetic gastroparesis when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Diabetic gastroparesis? *

Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 7 people, 46.67%
Diabetes: 7 people, 46.67%
Type 2 Diabetes: 7 people, 46.67%
Diabetes Mellitus Inadequate Control: 5 people, 33.33%
Neuropathy Peripheral (surface nerve damage): 5 people, 33.33%
Hyperglycemia (high blood sugar): 4 people, 26.67%
Renal Disorder (kidney disease): 4 people, 26.67%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 3 people, 20.00%
Type 1 Diabetes: 3 people, 20.00%
Acute Kidney Failure: 3 people, 20.00%

What are the existing conditions these people have? *

Stress And Anxiety: 4 people, 26.67%
Sleep Disorder: 3 people, 20.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 13.33%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Psychotic Disorder: 1 person, 6.67%
Pain: 1 person, 6.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 6.67%
Mania (a state of abnormally elevated or irritable mood): 1 person, 6.67%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Diabetic gastroparesis?

- Check whether Diabetic gastroparesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,455 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetic gastroparesis:

Diabetic gastroparesis (150 drugs)

Browse all the conditions that are associated with Diabetic gastroparesis:

Diabetic gastroparesis (244 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.